KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Operating Expenses (2016 - 2026)

Idexx Laboratories has reported Operating Expenses over the past 17 years, most recently at $342.5 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 10.85% year-over-year to $342.5 million; the TTM value through Dec 2025 reached $1.3 billion, up 3.91%, while the annual FY2025 figure was $1.3 billion, 3.91% up from the prior year.
  • Operating Expenses for Q4 2025 was $342.5 million at Idexx Laboratories, up from $328.5 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $355.4 million in Q2 2024 and troughed at $108.3 million in Q1 2021.
  • A 5-year average of $206.4 million and a median of $137.9 million in 2023 define the central range for Operating Expenses.
  • Biggest five-year swings in Operating Expenses: tumbled 33.48% in 2023 and later soared 160.96% in 2024.
  • Year by year, Operating Expenses stood at $128.8 million in 2021, then dropped by 1.79% to $126.5 million in 2022, then grew by 9.78% to $138.8 million in 2023, then surged by 122.55% to $309.0 million in 2024, then increased by 10.85% to $342.5 million in 2025.
  • Business Quant data shows Operating Expenses for IDXX at $342.5 million in Q4 2025, $328.5 million in Q3 2025, and $321.7 million in Q2 2025.